US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Recro Pharma Inc (REPH)
Recro Pharma Inc (REPH) ニュース

REPH

Recro Pharma (REPH)

Recro Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:REPH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/07	05 : 38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:REPH	Recro Pharma Inc
2023/06/03	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/27	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/05/23	06 : 11	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/20	05 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/05/19	06 : 00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/05/11	05 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/05/04	05 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/04/06	21 : 26	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:REPH	Recro Pharma Inc
2023/03/25	05 : 07	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:REPH	Recro Pharma Inc
2023/03/25	05 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/03/13	20 : 40	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/03/02	07 : 01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:REPH	Recro Pharma Inc
2023/03/02	06 : 58	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:REPH	Recro Pharma Inc
2023/03/02	06 : 52	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:REPH	Recro Pharma Inc
2023/03/02	06 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2023/02/15	04 : 58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:REPH	Recro Pharma Inc
2023/02/10	23 : 09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:REPH	Recro Pharma Inc
2023/02/03	07 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/01/21	06 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/01/06	06 : 33	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:REPH	Recro Pharma Inc
2023/01/06	06 : 20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:REPH	Recro Pharma Inc
2023/01/04	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2022/12/21	06 : 56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:REPH	Recro Pharma Inc
2022/12/17	07 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:REPH	Recro Pharma Inc

Showing the most relevant articles for your search:NASDAQ:REPH

1 2 3 4 5 6 7 8 9 10 次へ >>

Seigniorage Shares

Copperleaf Technologies (PK)

Diamond Platform Token

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約